Medivie Therapeutic Ltd Working Capital to Net Assets Ratio
Medivie Therapeutic Ltd working capital to net assets ratio. Medivie Therapeutic Ltd (MDVI) has a Working Capital to Net Assets ratio of 126.6% as of June 2021. Working capital of ILA-5.64 Million (current assets of ILA3.22 Million minus current liabilities of ILA8.86 Million) is measured against net assets of ILA-4.46 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. Check MDVI tangible net assets ratio to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Medivie Therapeutic Ltd (2010–2020)
Working capital to net assets ratio of Medivie Therapeutic Ltd from 2010 to 2020. This chart shows how Medivie Therapeutic Ltd's Working Capital to Net Assets ratio has evolved across 11 annual periods from 2010 to 2020. As of June 2021, the ratio stands at 126.6%, reflecting working capital of ILA-5.64 Million against net assets of ILA-4.46 Million ILA. See Medivie Therapeutic Ltd defensive interval ratio to measure how many days the company can operate on defensive assets alone.
Medivie Therapeutic Ltd Working Capital to Net Assets Ratio by Year (2010–2020)
Medivie Therapeutic Ltd working capital to net assets ratio by year from 2010 to 2020. The table below presents the year-by-year Working Capital to Net Assets ratio for Medivie Therapeutic Ltd from 2010 to 2020, covering 11 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see Medivie Therapeutic Ltd assets under control.
| Year | WC/NA Ratio | Working Capital (ILA) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2020 | -74.0% | ILA-2.76 Million | ILA3.73 Million | ILA5.07 Million | ILA7.82 Million | ▼ -111.3 pp |
| 2019 | 37.3% | ILA2.19 Million | ILA5.88 Million | ILA8.72 Million | ILA6.53 Million | ▼ -22.6 pp |
| 2018 | 59.9% | ILA7.29 Million | ILA12.18 Million | ILA11.61 Million | ILA4.32 Million | ▲ +33.6 pp |
| 2017 | 26.3% | ILA4.27 Million | ILA16.26 Million | ILA7.72 Million | ILA3.45 Million | ▼ -67.2 pp |
| 2016 | 93.4% | ILA539.00K | ILA577.00K | ILA2.34 Million | ILA1.80 Million | ▼ -26.5 pp |
| 2015 | 119.9% | ILA-632.00K | ILA-527.00K | ILA473.00K | ILA1.10 Million | ▲ +20.4 pp |
| 2014 | 99.5% | ILA2.25 Million | ILA2.26 Million | ILA3.87 Million | ILA1.62 Million | ▼ -2.6 pp |
| 2013 | 102.1% | ILA-1.55 Million | ILA-1.52 Million | ILA495.00K | ILA2.05 Million | ▲ +38.8 pp |
| 2012 | 63.3% | ILA773.00K | ILA1.22 Million | ILA2.13 Million | ILA1.36 Million | ▼ -206.1 pp |
| 2011 | 269.4% | ILA9.84 Million | ILA3.65 Million | ILA12.33 Million | ILA2.48 Million | ▲ +260.8 pp |
| 2010 | 8.6% | ILA-488.00K | ILA-5.68 Million | ILA2.93 Million | ILA3.42 Million | — |